Bayer Pays $15M To Soothe Consumers In Aspirin MDL

Law360, New York (May 17, 2012, 4:01 PM EDT) -- Bayer Corp. has agreed to pay $15 million to resolve class action claims that it misled consumers into believing its combination aspirin drugs had received regulatory approval, according to a settlement motion filed in New York federal court Wednesday.

Purchasers of Bayer's enhanced aspirin pills asked the court to sign off on a settlement that will end a multidistrict litigation accusing the drugmaker of selling two separate combination pills that had not been rubber-stamped by the U.S. Food and Drug Administration, saying that the payout represented...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.